Development Agreement

12 April 2010

Agreement signed to establish manufacturing capability for Chewitab™

Oxford Nutrascience Group plc ("Oxford Nutrascience" or "the Company") announces that it has signed a development agreement with Surepharm Services Limited to scale-up and validate manufacturing processes for its Chewitab™ delivery systems.

Chewitab™ is the Company's brand name for its chewable tablet for vitamins and medicines. Prototypes produced by Oxford Nutrascience have performed well and under the terms of the agreement Surepharm will be responsible for demonstrating the manufacturing processes as the Company moves towards the commercialisation of its Chewitab™ products.

Oxford Nutrascience intends to launch Chewitab™ products including a chewable calcium supplement and a chewable multi-vitamin supplement as well as license the technology to over-the-counter consumer healthcare companies.

Nigel Theobald, Chief Executive, Oxford Nutrascience Group Plc commented:

"The performance of the Chewitab prototypes in our laboratories has been excellent and prototypes have been well received by a number of major consumer healthcare companies in several markets around the world.

"By working closely with our development partners, Oxford Nutrascience is now ready to move to its next phase and demonstrate that our products can be produced on a mass scale.

"The signing of this development agreement is an important step towards the use of our technology in making self medication easier. Initial interest is already being shown by a number of the major brand owners in the consumer healthcare pharmaceutical sectors to license our technology."

- Ends -

For further information:

www.oxfordnutrascience.com

Oxford Nutrascience Group Plc

Nigel Theobald, Chief Executive +44 1865 854874

Mark Way, Investor and Media Relations +44 7786 116991

ZAI Corporate Finance (Nominated Adviser)

John Depasquale +44 20 7060 2220

Sarang Shah +44 20 7060 2220

About Oxford Nutrascience Group Plc

·; Oxford Nutrascience is a UK consumer healthcare company that develops chewy confectionery, chewable tablets and liquid suspensions to allow medicines and vitamin supplements to be taken in a more pleasant and convenient way.

·; Oxford Nutrascience has developed technology for the use of prebiotic soluble fibres in medicine delivery systems that disperse and solubilise medicines, improve taste and mouth feel, simplify processing and eliminate additives, incorporate prebiotic health benefits.

·; Chews: Oxford Nutrascience currently produces Ellactiva®, a calcium chewy supplement sold in the UK and in the Middle East, and plans to launch new chews to complement this existing product.

·; Chewable tablets and liquid suspensions: The target market for Oxford Nutrasciences' Chewitabs™ and liquid suspension delivery systems are over-the-counter ("OTC") pain relieving drugs, indigestion preparations and cough and cold medicines.

·; Oxford Nutrascience's medicine development work is currently focused on ibuprofen suspension and chewable allergy tablets incorporating loratadine.